WallStreetZenWallStreetZen

NASDAQ: ZYME
Zymeworks Inc Earnings & Revenue

ZYME past revenue growth

How has ZYME's revenue growth performed historically?
Company
-88.69%
Industry
89.94%
Market
19.39%
ZYME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZYME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZYME's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZYME earnings and revenue history

Current Revenue
$50.5M
Current Earnings
-$126.0M
Current Profit Margin
-249.6%

ZYME Return on Equity

Current Company
-28.4%
Current Industry
16.8%
Current Market
28.2%
ZYME's Return on Equity (-28.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZYME announces earnings.

ZYME Return on Assets

Current Company
-22%
Current Industry
3.2%
ZYME is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZYME Return on Capital Employed

Current Company
-25.73%
Current Industry
-42.4%
ZYME has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZYME vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZYME$50.46M-$111.14M-$125.97M-4.91%N/A
ORIC$0.00-$100.72M-$101.76MN/AN/A
ABUS$12.99M-$72.66M-$74.39M+20.14%N/A
TVTX$183.23M-$110.58M-$161.13M+2.07%N/A
SRRK$0.00-$173.63M-$183.26M-100.00%N/A

Zymeworks Earnings & Revenue FAQ

What were ZYME's earnings last quarter?

Zymeworks (NASDAQ: ZYME) reported Q1 2024 earnings per share (EPS) of -$0.42, up 16.67% year over year. Total Zymeworks earnings for the quarter were -$31.65 million. In the same quarter last year, Zymeworks's earnings per share (EPS) was -$0.36.

If you're new to stock investing, here's how to buy Zymeworks stock.

What was ZYME's earnings growth in the past year?

As of Q3 2024, Zymeworks's earnings has grown year over year. Zymeworks's earnings in the past year totalled -$125.97 million.

What was ZYME's revenue last quarter?

Zymeworks (NASDAQ: ZYME) reported Q1 2024 revenue of $10.03 million up 71.81% year over year. In the same quarter last year, Zymeworks's revenue was $35.58 million.

What was ZYME's revenue growth in the past year?

As of Q3 2024, Zymeworks's revenue has grown -88.69% year over year. This is 178.63 percentage points lower than the US Biotechnology industry revenue growth rate of 89.94%. Zymeworks's revenue in the past year totalled $50.46 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.